Original Investigations: Pathogenesis and Treatment of Kidney Disease and Hypertension
Albumin to creatinine catio: A screening test with limitations

https://doi.org/10.1053/ajkd.2002.33388Get rights and content

Abstract

The aim of this study is to assess the effects of age on (1) the ability of a spot albumin-creatinine ratio (ACR) to accurately predict 24-hour albumin excretion rate (AER), and (2) the performance of spot ACR as a screening test for microalbuminuria. Three hundred fourteen patients with diabetes aged 18 to 84 years attending a tertiary outpatient clinic underwent one 24-hour urine collection and, immediately after completion, provided one fasting spot morning urine sample. Twenty-four-hour AER and spot ACR were determined. Performance of spot ACR was assessed according to age and sex. Fifty-three percent of men and 32% of women had an AER of 20 μg/min or greater. Multiple regression analysis showed age was an independent predictor of spot ACR. For an AER of 20 μg/min for patients in the age range of 40 to 80 years, there was an increase in corresponding values for spot ACR from 18.2 mg/g (95% confidence interval [CI], 15.6 to 21.3) to 32.5 mg/g (95% CI, 27.5 to 38.4) in men and from 22.1 mg/g (95% CI, 18.0 to 27.1) to 56.4 mg/g (95% CI, 47.2 to 67.4) in women. Using ACR cutoff values of 22.1 mg/g or greater and 30.9 mg/g or greater in conventional units (equivalent to ≥2.5 and ≥3.5 mg/mmol in SI units) in men and women, the spot ACR provided high sensitivities (men, 95.7%; women, 93.35%) and had excellent receiver operator characteristic curves, respectively. However, the spot ACR false-positive rate increased with age from 15.9% (age, 40 to 65 years) to 31.8% (>65 years) in men and from 10.5% (age, 45 to 65 years) to 28.3% (>65 years) in women. Spot ACR is a good screening test for microalbuminuria, but a poor predictor of quantitative AER, and should not be used as a diagnostic test. The increase in spot ACR relative to 24-hour AER with age supports the use of sex- and age-adjusted ACR cutoff values. © 2002 by the National Kidney Foundation, Inc.

Section snippets

Patients

In this prospective study, 385 consecutive samples were collected over a 6-month period from patients with type 1 (30%) and type 2 (70%) diabetes undergoing routine assessment for diabetic kidney disease at the Austin and Repatriation Medical Center (Heidelberg, Victoria, Australia). Of subjects with type 2 diabetes, 51% were women and 49% were men. Subjects undertaking assessment of AER were asked to avoid strenuous exercise the day of the urine collection. Each patient provided one timed

Effect of age on albumin and creatinine excretion

Patient characteristics are listed in Table 1.

. Clinical and Biochemical Characteristics of Patients

Empty CellMenWomenP*
No. of patients173141
Age (y)59 ± 162 ± 10.05
Age by group (y)0.46
 <4019 (11)13 (9)
 40-6579 (46)57 (40)
 >6575 (43)71 (50)
24-Hour AER (μg/min)31 ×/÷ 1.118 ×/÷ 1.1<0.001
AER by group<0.001
 Normoalbuminuria81 (47)96 (68)
 Microalbuminuria72 (42)37 (26)
 Macroalbuminuria20 (12)8 (6)
24-Hour UCreat (mg/d)1,413 ± 30975 ± 23<0.001
Spot ACR (mg/g)38 ×/÷ 1.134 ×/÷ 1.10.54
*Unpaired t-tests, except

Discussion

This study shows an important association between age and the relationship between AER and ACR in both sexes. Age has not been widely recognized as an important predictor of ACR, and current guidelines only take sex into account.5 In one previous study examining the interindividual variability of UCreat excretion and its influence on ACR in subjects with diabetes, only sex and body mass index, but not age, were found to be significant determinants.1 However, on that study, subjects were studied

Acknowledgements

The authors thank Mary Tsamitros, hospital scientist, for technical assistance with the measurement of UCreat.

References (21)

  • CE Mogensen et al.

    Prevention of diabetic renal disease with special reference to microalbuminuria

    Lancet

    (1995)
  • SJ Connell et al.

    Gender and the clinical usefulness of the albumin:creatinine ratio

    Diabet Med

    (1994)
  • PH Bennett et al.

    Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation

    Am J Kidney Dis

    (1995)
  • G Jerums et al.

    Microalbuminuria in diabetes

    Med J Aust

    (1994)
  • GCMC Viberti et al.

    St Vincent Declaration, Guidelines for the prevention of diabetic renal failure

  • J Warram et al.

    Use of the albumin/creatinine ratio in patient care and clinical studies

  • JN Harvey et al.

    Prediction of albumin excretion rate from albumin-to-creatinine ratio

    Diabetes Care

    (1999)
  • AJ Bakker

    Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration

    Diabetes Care

    (1999)
  • AS Hutchison et al.

    Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria

    Clin Chem

    (1988)
  • JP Shield et al.

    Screening for diabetic microalbuminuria in routine clinical care: Which method?

    Arch Dis Child

    (1995)
There are more references available in the full text version of this article.

Cited by (84)

  • Type 2 Diabetes in Children and Adolescents

    2018, Canadian Journal of Diabetes
  • Type 1 Diabetes in Children and Adolescents

    2018, Canadian Journal of Diabetes
    Citation Excerpt :

    Individuals with intermittent albuminuria may progress to overt nephropathy (159). Abnormal screening results require confirmation and follow up to demonstrate persistent abnormalities, as albuminuria can and is more likely to regress in youth compared to older adults (160–162). Treatment is indicated only for those adolescents with persistent albuminuria.

  • Age- and gender-specific reference values for urine albumin/creatinine ratio in children of southwest China

    2014, Clinica Chimica Acta
    Citation Excerpt :

    Similar race-specific differences were also found among non-Hispanic whites (7.2%) compared with non-Hispanic blacks (10.2%). Houlihan et al. [27] evaluated the characteristics of the ACR using gender-specific cutoff values (22.1 mg/g in men and 30.9 mg/g in women) as a screening tool and found that spot ACR testing provided high sensitivities (95.7% for men and 93.35% for women) [27]. These studies indicate that gender- and race-specific ACR reference values should be determined for children as well.

View all citing articles on Scopus

Address reprint requests to George Jerums, MD, Endocrine Unit, Austin and Repatriation Medical Centre, Studley Rd, Heidelberg 3084, Victoria, Australia. E-mail: [email protected]

0272-6386/02/3906-0008$35.00/0

View full text